Αρχειοθήκη ιστολογίου

Δευτέρα 9 Απριλίου 2018

Spasmodic Dysphonia in Multiple Sclerosis Treatment With Botulin Toxin A: A Pilot Study

This study aims to evaluate the effect of botulin toxin A in patients with multiple sclerosis (MS) affected by spasmodic dysphonia (SD) and to show the safety and effectiveness of this treatment in long-term observation.

from #ORL-AlexandrosSfakianakis via ola Kala on Inoreader https://ift.tt/2qi2Y6W

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου